This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock Cesca Therapeutics Short Interest DataCesca Therapeutics (KOOL) has a short interest of 208,500 shares, representing 12.05% of the float (the number of shares available for trading by the public). This marks a 14.12% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.0, indicating that it would take 1.0 days of the average trading volume of 112,188 shares to cover all short positions.Current Short Interest208,500 sharesPrevious Short Interest182,700 sharesChange Vs. Previous Month+14.12%Dollar Volume Sold Short$1.15 millionShort Interest Ratio1.0 Days to CoverLast Record DateOctober 15, 2019Outstanding Shares2,416,000 sharesFloat Size1,730,000 sharesShort Percent of Float12.05%Today's Trading Volume13,993 sharesAverage Trading Volume112,188 sharesToday's Volume Vs. Average12% Short Selling Cesca Therapeutics? Sign up to receive the latest short interest report for Cesca Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Cesca Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date KOOL Short Interest - Frequently Asked Questions What is Cesca Therapeutics' current short interest? Short interest is the volume of Cesca Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 208,500 shares of KOOL short. 12.05% of Cesca Therapeutics' shares are currently sold short. Learn More on Cesca Therapeutics' current short interest. What is a good short interest ratio for Cesca Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KOOL shares currently have a short interest ratio of 1.0. Learn More on Cesca Therapeutics's short interest ratio. What is a good short interest percentage for Cesca Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.05% of Cesca Therapeutics' floating shares are currently sold short. Is Cesca Therapeutics' short interest increasing or decreasing? Cesca Therapeutics saw a increase in short interest in October. As of October 15th, there was short interest totaling 208,500 shares, an increase of 14.1% from the previous total of 182,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Cesca Therapeutics' float size? Cesca Therapeutics currently has issued a total of 2,416,000 shares. Some of Cesca Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cesca Therapeutics currently has a public float of 1,730,000 shares. How does Cesca Therapeutics' short interest compare to its competitors? 12.05% of Cesca Therapeutics' shares are currently sold short. Here is how the short interest of companies compare to Cesca Therapeutics: Kewaunee Scientific Co. (2.17%), C4 Therapeutics, Inc. (9.03%), Exagen Inc. (0.98%), Coya Therapeutics, Inc. (1.90%), Coherus BioSciences, Inc. (28.09%), Agape ATP Co. (0.66%), Contineum Therapeutics, Inc. (4.28%), Genelux Co. (6.63%), Kyverna Therapeutics, Inc. (10.90%), MacroGenics, Inc. (9.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Alibaba Group Holding Limited ($3.24 billion), Sempra ($2.36 billion), Digital Realty Trust, Inc. ($1.78 billion), Twilio Inc. ($1.67 billion), Alexandria Real Estate Equities, Inc. ($1.27 billion), Insulet Co. ($909.50 million), Guidewire Software, Inc. ($704.80 million), Zendesk, Inc. ($602.65 million), Medidata Solutions Inc ($560.77 million), and Prosperity Bancshares, Inc. ($437.13 million). View all of the most shorted stocks. What does it mean to sell short Cesca Therapeutics stock? Short selling KOOL is an investing strategy that aims to generate trading profit from Cesca Therapeutics as its price is falling. KOOL shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cesca Therapeutics? A short squeeze for Cesca Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KOOL, which in turn drives the price of the stock up even further. How often is Cesca Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KOOL, twice per month. The most recent reporting period available is October, 15 2019. More Short Interest Resources from MarketBeat Related Companies KEQU Short Interest Data CCCC Short Interest Data XGN Short Interest Data COYA Short Interest Data CHRS Short Interest Data ATPC Short Interest Data CTNM Short Interest Data GNLX Short Interest Data KYTX Short Interest Data MGNX Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KOOL) was last updated on 5/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery A shocking bill has been put before the House of Representatives… Representative Brandon Gill wants Preside...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAI Firm Enters America's Largest Medicaid MarketNew York's $95B system just approved a new AI healthcare platform. Here's what to know. A major shift in U....i2i Marketing Group, LLC | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.